- Home
- SABR vs PACB Comparison
SABR vs PACB Comparison
Compare SABR & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | PACB |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | 575 |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.7M | 459.0M |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SABR | PACB |
|---|---|---|
| Price | $1.55 | $1.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $3.70 | $2.20 |
| AVG Volume (30 Days) | ★ 16.7M | 5.9M |
| Earning Date | 05-21-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 283.56 | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $3,866,956,000.00 | $93,468,000.00 |
| Revenue This Year | $7.40 | $11.22 |
| Revenue Next Year | $3.26 | $12.41 |
| P/E Ratio | $1.20 | ★ N/A |
| Revenue Growth | ★ 7.46 | 3.04 |
| 52 Week Low | $0.81 | $0.85 |
| 52 Week High | $3.86 | $2.73 |
Technical Indicators
Market Signals| Indicator | SABR | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 58.34 | 33.19 |
| Support Level | $1.20 | $1.36 |
| Resistance Level | $1.70 | $1.73 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 64.29 | 5.66 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company sold its growing hotel IT solutions division (9% of revenue) to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.